GCG and metabolic dysfunction-associated steatotic liver disease: A recent study showed similar levels of GLP-1 in the serum of NAFLD patients and healthy controls but detected a downregulation of the hepatic GLP-1 receptor (GLP-1R) in NAFLD patients.